Overview

Silodosin in Retrograde Intrarenal Surgery

Status:
COMPLETED
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
Selective alpha-blockers have been used for the treatment of ureteric stones as medical expulsive therapy (MET). Recently they have been successfully used in passive ureteric dilatation before semirigid ureteroscopy. This study enables us to know the role of silodosin in ureteric dilatation to facilitate ureteral access sheath placement in Retrograde Intrarenal Surgery with flexible ureteroscopy.
Phase:
PHASE3
Details
Lead Sponsor:
Ain Shams University
Treatments:
silodosin